Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2009 2
2016 1
2020 1
2021 1
2022 4
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Savatenkov
Page 1
Immunotherapy and Hepatocellular Cancer: Where Are We Now?
Valery M, Cervantes B, Samaha R, Gelli M, Smolenschi C, Fuerea A, Tselikas L, Klotz-Prieux C, Hollebecque A, Boige V, Ducreux M. Valery M, et al. Cancers (Basel). 2022 Sep 19;14(18):4523. doi: 10.3390/cancers14184523. Cancers (Basel). 2022. PMID: 36139683 Free PMC article. Review.
Rechallenge After Oxaliplatin-Induced Hypersensitivity Reactions.
Rassy E, Le Roy F, Smolenschi C, Valéry M, Boige V, Ducreux M, Boilève A. Rassy E, et al. Among authors: valery m. JAMA Oncol. 2023 Mar 1;9(3):434-435. doi: 10.1001/jamaoncol.2022.7136. JAMA Oncol. 2023. PMID: 36701137 Free PMC article.
Precision medicine for KRAS wild-type pancreatic adenocarcinomas.
Ben-Ammar I, Rousseau A, Nicolle R, Tarabay A, Boige V, Valery M, Pudlarz T, Malka D, Gelli M, Fernandez-De-Sevilla E, Fuerea A, Tanguy ML, Rouleau E, Barbe R, Mathieu JRR, Jaulin F, Smolenschi C, Hollebecque A, Ducreux M, Boileve A. Ben-Ammar I, et al. Among authors: valery m. Eur J Cancer. 2024 Jan;197:113497. doi: 10.1016/j.ejca.2023.113497. Epub 2023 Dec 15. Eur J Cancer. 2024. PMID: 38134480
Pancreatic adenocarcinoma third line systemic treatments: a retrospective cohort study.
Gueiderikh A, Tarabay A, Abdelouahab M, Smolenschi C, Tanguy ML, Valery M, Malka D, Pudlarz T, Fuerea A, Boige V, Hollebecque A, Ducreux M, Boilève A. Gueiderikh A, et al. Among authors: valery m. BMC Cancer. 2024 Feb 26;24(1):272. doi: 10.1186/s12885-024-12016-z. BMC Cancer. 2024. PMID: 38408958 Free PMC article.
Precision Medicine in Pancreatic Ductal Adenocarcinoma: The Impact of Targeted Therapies on Survival of Patients Harboring Actionable Mutations.
Tarabay A, Boileve A, Smolenschi C, Antoun L, Valery M, Fuerea A, Perret A, Burtin P, Cosconea S, Belkhodja H, Malka D, Boige V, Hollebecque A, Ducreux M. Tarabay A, et al. Among authors: valery m. Biomedicines. 2023 Sep 19;11(9):2569. doi: 10.3390/biomedicines11092569. Biomedicines. 2023. PMID: 37761010 Free PMC article.
16 results